www.public4you.fora.pl

troyolwtcc

About 2900 trademarks are current registered in Australia covering cigarettes,[link widoczny dla zalogowanych], and there are another 180 or so pending applications. But consumers do not see 3000 different brands of cigarettes when they go into a shop. What is happening is that the cigarette companies in many cases are double dipping,[link widoczny dla zalogowanych], and obtaining multiple trademark registrations for each brand they own.
There are 17 trademark registrations and applications including the word Winfield, 22 including Pall Mall, and 11 including Horizon. These registrations include the basic plain word mark?—?Horizon is registration 203429 dating from 1966, Pall Mall is registration 1062086 dating from 2005. But in addition to the plain version, which protects the mark in whatever appearance it is used, the cigarette companies have also re-registered the mark in a narrower form,[link widoczny dla zalogowanych], including the get-up of the cigarette packaging.
BAT’s TM registrations Nos.1226909, 1226913, 1226914, and 1226915 (without a colour restriction), all dating from 2008,[link widoczny dla zalogowanych], cover different variations of the Pall Mall packaging: If our government declined to take action every time an industry alleged its rights were being affected and the industry was therefore entitled to compensation,[link widoczny dla zalogowanych], it would probably never take any action. Instead of measuring the volume of the complaint,[link widoczny dla zalogowanych], we should examine the legitimacy of the arguments and any conflict of interests of those who make the arguments.
The tobacco industry’s legal arguments are simply not credible. They are a smokescreen designed to scare the government into backing down. As to conflicts of interest, I should declare mine. On two occasions, the Cancer Council Victoria has supplied me with some very nice sandwiches and some orange juice, although I suspect the orange juice may have been reconstituted rather than fresh. Darpa’s been funding fast-tracked medication production since 2005, when the agency launched their Accelerated Manufacture of Pharmaceuticals (AMP) program.
Although Darpa was already funding research into Avian Flu protection,[link widoczny dla zalogowanych], they realized that H1N1 was a more pressing priority. “In response to the 2009 H1N1 swine flu pandemic, AMP’s plant-based platform redirected its rapid scale-up processes that were initially developed for avian influenza,[link widoczny dla zalogowanych],” Darpa’s announcement states.
The Texas A&M consortium also received $21 million from Darpa for the creation of Project GreenVax, which will work towards the quick, plant-based production of a myriad of vaccines. Having the program in place would offer a method to mitigate newly emerging viruses before they turn into widespread pandemics. The project will be housed in a custom-built, 21-acre compound, which features a 145,000 square foot “biotherapeutic production facility” that uses mobile “pods” to grow the plants.